SKAN Research Trust, promoted by Bengaluru-based entrepreneur Ashok Soota and UK-based Quadram Institute Bioscience have entered into a Comprehensive Partnership Agreement to collaborate on research programmes focused on gut health and developing therapies that alleviate ageing and neurological diseases.

The Quadram Institute Bioscience (QIB) and SKAN Research Trust direct considerable research resources towards addressing gut health and the gut-cardiovascular and gut-brain axes.

Important areas on which QIB and SKAN will collaborate under the terms of the Comprehensive Partnership Agreement include undertaking joint research projects in UK and India for the development of microbiome-based products that promote human health and treat neurological and age-related ailments; technology transfer between the organisations to augment cutting-edge Indian research capabilities; training of young Indian research scientists with Quadram Institute Bioscience and study of large Indian population cohorts to develop India-specific therapies that alleviate ageing and neurological diseases.

The India leg of the research project will commence once necessary approvals are secured from the Government of India.